Search results
Results from the WOW.Com Content Network
hide. The health effects of electronic cigarettes (e-cigarettes) include a range of potential risks such as exposure to toxic chemicals, the possibility of increased likelihood of respiratory and cardiovascular diseases, and concerns about their possible role in cancer development. Upon their introduction, there were marketing claims that they ...
The young adult heart attack rate has risen by 2/3rds in 4 years. In 2019, only 0.3% of U.S. adults between ages 18 and 44 had suffered a heart attack, according to data from the National Center ...
Vaping-associated pulmonary injury (VAPI), [ 4 ] also known as vaping-associated lung injury (VALI) [ 1 ] or e-cigarette, or vaping, product use associated lung injury (E/VALI), [ 2 ][ a ] is an umbrella term, [ 15 ][ 16 ] used to describe lung diseases associated with the use of vaping products that can be severe and life-threatening. [ 3 ]
Contrary to what many young adults believe, vaping is not "healthier" or "better for you" than lighting up a cigarette, experts warn. "Vaping is smoking and smoking is vaping," said Dr. Iyaad ...
The U.S. Centers for Disease Control and Prevention (CDC) and state health officials are still trying to define the illness and determine its cause. ... far have involved young men under the age ...
Many young people who would not smoke are vaping. [87] [55] Young people who smoke tobacco or marijuana, or who drink alcohol, are much more likely to vape. [88] [89] Among young people who have tried vaping, most used a flavored product the first time. [88] [90] Vaping correlates with smoking among young people, even in those who would ...
Vaping has been known for its association with respiratory disease and nicotine addiction.Now, a new study, building upon previous evidence, has found that among teens, vaping often may spike the ...
A 2018 Cochrane review found that, in rare cases, nicotine replacement therapy can cause non-ischemic chest pain (i.e., chest pain that is unrelated to a heart attack) and heart palpitations, but does not increase the incidence of serious cardiac adverse events (i.e., myocardial infarction, stroke, and cardiac death) relative to controls. [47]